Division of Hematology and Oncology Recent Grants & Awards
Active Research Support
Clinical Trials
Santosh Saraf, MD Heading link
- R01 (PI) “Pathways of Cell-free hemoglobin in Sickle Cell Nephropathy”
- R01 (MPI) “Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models”
- R01 (CoI) “Improving Scientific Rigor of Clinical Endpoints for Sickle Cell Anemia”
- R01 (CoI) “Molecular and Cellular Pathogenesis of Kidney Disease in Sickle Cell Disorders”
- U54 (Project Co-Leader) H3 Africa: Sickle Cell Disease Nephropathy
Global Blood Therapeutics (IIT PI) “A pilot study of Voxelotor for Sickle Cell anemia Patients at Highest Risk for Progression of Kidney Disease” - Novartis (IIT PI) “Clinical, Laboratory, and Genetic Predictors for Sickle cell Nephropathy”
Sean Quigley, MD Heading link
- 2U54DK083909-11, (Desnick (PI)), $1.4 M/year, 08/2019–08/2024
Agency: NIDDK, Porphyria Consortium
Clinical research support for porphyria studies (Satellite site PI, clinical research coordinator support) - ACTIV-4 Program for COVID-19 patients, Krishnan (PI), $6M (est)., 09/2020–06/2022
Agency: NIH/NHLBI
Role: Co-Investigator (0.15 FTE). - ACTIV-4a, 4c studies, Quigley, J (PI, Illinois), ~$3M (est; ~$1M accrued to date), 09/2020–12/2022.
Agency: NIH/NHLBI
Roles: PI for both these In-Hospital and Post-Hospital discharge anticoagulation trials for COVID-19 patients, 2.4 cal. months - ACTIV-4 Program ILLI-NET award, Quigley (Co-PI), $3M (est).
Agency: NIH/NHLBI
Roles: Co-PI for both ACTIV-4a, -4c Illinois Hospitals Networks, 1.2 cal. months - OTA-21-015B, Post-Acute Sequelae of SARS-CoV-2 Infection, Krishnan (PI), 09/2021–09/2025, est. $20M
Agency: NIH
Role: Co-I, Hematology/Thrombosis clinical research aspects, for UIC and for ILLI-NET, 1.2 cal. Months - ACTIV-4d, Collins, ~$200K to UIC (est), 06/2021–06/2022
Agency: NIH/NHLBI
Role: PI for UIC, RAAS trial for COVID-19 patients, 1.2 cal. months
Kent Hoskins, MD Heading link
- American Cancer Society
(Kitajewski-Center PI; Hoskins, PI of Research Scholar Grant Project 3)
Project title: Illinois Cancer Health Equity Research Center
Research Scholar Grant Project 3 title: Creation of a Culturally Sensitive Narrative Intervention to Promote Equity in Clinical Trials Participation. - NIH/NCI
Grant number: K01CA248852 (Henderson)
Project title: Promoting Genetic Counseling among African American Women with Hereditary Risk for Breast Cancer
Role: UIC sub-award Principal Investigator - American Heart Association (PI, Beyer)
Project title: “Taking Charge During Treatment: exercise to improve fitness and quality of life among diverse breast cancer survivors”
Role: Co-Investigator
Department of Defense Breakthrough Award (Hoskins, PI)
Project title: “Therapeutic Benefit of Potassium Channel Activators in Triple-Negative Breast Cancer.”
Role: Partnering Principal Investigator
NIH/NCI (Raychaudhuri, PI)
Project title: Repression function of FoxM1 in tumor metastasis
Role: Co-Investigator